The study objective was to compare the change in the rate of memory decline after PCI vs CABG.
For patients with established atherosclerotic cardiovascular disease, there is no significant difference in cardiovascular events or major bleeding for those receiving 81 mg or 325 mg of aspirin daily.
Austrian researchers investigated the utility of remnant cholesterol as a marker of cardiovascular event risk in coronary artery disease.
Subclinical hypothyroidism is reportedly associated with an increased risk of adverse events in patients undergoing coronary angioplasty.
Mortality risk lower with PDE5i treatment versus alprostadil treatment; similar links seen for MI, heart failure, CV mortality risk.
Researchers compared a potent antiplatelet inhibition strategy with a less potent inhibition treatment plan in patients with acute coronary syndrome undergoing coronary artery bypass surgery.
For patients returning to work after first myocardial infarction, the risk for recurrent coronary heart disease.
Compared with never smokers, current smokers have increased odds of having coronary artery calcification score.
The Harmony TPV System provides less invasive option to treat pulmonary regurgitation in patients with native or surgically repaired right ventricular outflow tract.
From 2008 to 2017, the rates of cardiovascular diseases declined in the year after MI, with greater reductions seen for women than men.